Posts Tagged ‘NIH’

Funding Focus – New NIH Biosketch Format, Feb. 19

Research Funding and Development Services will resume hosting monthly Funding Focus workshops every third Thursday beginning in February.  First up: Advice on the new NIH Biosketch format requirements.  In the meantime, for questions on the new format, please see the most recent NIH announcement, which includes instructions and samples. In addition, the Science Experts Network (SciENcv) is now up and running and available to support the new biosketch format. A YouTube video provides instructions for … Read More

NIH Fiscal Policy for FY2015

Need budget guidance for NIH awards? Here’s the latest: Funding levels for noncompeting renewals, which have been at about 90% of award, will likely be restored. Those that have yet to be awarded may be awarded in a range between full commitment level to 3% below. See your specific IC for more information. NRSA stipends will increase by about 2%. New investigators should still retain their ‘bonus’. Salaries are capped at $183,300. Responses to more … Read More

NIH Salary Guidance for FY2015

The salary cap for NIH awards will increase from $181,500 to $183,300, beginning January 11, 2015. What does this mean for you? See examples and scenarios in the full notice or talk to your OPAM representative.

NRSA Stipends Set for 2015

The new levels for stipends, tuition, institutional allowances, and other relevant budget items have now been updated for all Ruth L. Kirschstein (NRSA) and T32 (and other institutional training) awards. See the full notice here.

Standard application due date changes for SBIRs/STTRs

The National Institutes of Health is changing its standard application dates for SBIRs/STTRs to speed up the disbursal of funds to successful applicants. The current deadlines are April 5, August 5, and December 5. Beginning in September 2015, the new dates will be September 5, January 5, and April 5. Essentially, this means that the next two deadlines for this mechanism are April 5, 2015, and September 5, 2015, with the August 5 deadline being eliminated. … Read More

NIH simplifies the process for late applications

The National Institutes of Health has updated and simplified its policy on submitting late applications, beginning with applications due January 25, 2015 or later. They have added a two week window after the due date during which a request to accept a late application may be considered, and they have eliminated the previous practice of assigning different late application windows to different funding mechanisms, or in some cases, not allowing them at all. Now, all … Read More

NIH is really, truly implementing the new biosketch format

While you were enjoying your holidays, Sally Rockey announced last week that the NIH really, truly is implementing the new 5-page biosketch format with the annotated bibliography section detailing the importance of your contributions to science. This format applies to projects beginning in 2016, but that means applications with due dates as early as January 2015–so it’s not too soon to start preparing. This change will require you to spend some time thinking about, rewriting, … Read More

NIH Common Fund Video Competition winners announced

Did you know that the NIH Common Fund was holding a video competition to commemorate its 10-year anniversary? Neither did we, but after seeing this Common Fund rap, we will definitely be going with the Common Fund.

Peter Barr-Gillespie and Kateri Spinelli win BioArt Competition

Dr. Peter Barr-Gillespie, Ph.D, and Kateri Spinelli, Ph.D. are one of 12 winners of the 2014 Federation of American Societies for Experimental Biology (FASEB) annual BioArt competition. Their submission, showing the sensory hair cells of a chick, was captured by scanning electron microscopy. The image comes from joint work to discover better methods to detect and treat hearing loss and disrupted balance. The 12 winning images and videos demonstrate the breadth of ongoing research in … Read More

Vaccine & Gene Therapy Institute’s Jay Nelson awarded vaccine adjuvant discovery contract

Jay Nelson, director of the OHSU Vaccine & Gene Therapy Institute, has been awarded a $10 million contract from the National Institutes of Health for discovery work on new ways to improve vaccines. They were one of seven groups awarded such contracts. Vaccine adjuvants are compounds that bolster the innate immune response, essentially super-charging the vaccine. While adjuvants show great promise in improving vaccines and fighting disease, currently  just three are in use–scientists at VGTI … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives